Anti-bevacizumab idiotype antibody vaccination is effective in inducing vascular endothelial growth factor-binding response, impairing tumor outgrowth. [electronic resource]
Producer: 20160825Description: 551-5 p. digitalISSN:- 1349-7006
- Angiogenesis Inhibitors -- administration & dosage
- Animals
- Antibodies, Anti-Idiotypic -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Bevacizumab -- administration & dosage
- Cell Line, Tumor
- Humans
- Melanoma, Experimental -- drug therapy
- Mice
- Neovascularization, Pathologic -- drug therapy
- Vascular Endothelial Growth Factor A -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.